Copyright
©The Author(s) 2025.
World J Hepatol. Feb 27, 2025; 17(2): 101741
Published online Feb 27, 2025. doi: 10.4254/wjh.v17.i2.101741
Published online Feb 27, 2025. doi: 10.4254/wjh.v17.i2.101741
Table 1 Clinical baseline characteristics of patients in the two groups
| DILI (n = 89) | DILI + NAFL (n = 110) | P value | |
| Age (year) | 51 (42, 58.5) | 55 (43.75, 59.25) | 0.224 |
| Females (number) | 70 (78.7) | 85 (77.3) | 0.816 |
| BMI (kg/cm²) | 23.55 (21.15, 25.83) | 25.4 (23.25, 28) | 0.019 |
| Liver stiffness (kPa) | 9.8 (7.8, 12.95) | 10.4 (6.65, 14.8) | 0.541 |
| CAP (Db/m) | 192 (171.5, 235.5) | 237 (195.5, 282) | 0 |
| Smoking history (number) | 12 (13.5) | 17 (15.1) | 0.485 |
- Citation: Zhao Y, Li JZ, Liu YG, Zhu YJ, Zhang Y, Zheng WW, Ma L, Li J, Wang CY. Clinical features and prognosis of drug-induced liver injury in patients with non-alcoholic fatty liver. World J Hepatol 2025; 17(2): 101741
- URL: https://www.wjgnet.com/1948-5182/full/v17/i2/101741.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i2.101741